We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · July 24, 2020

Safety of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema

The British Journal of Ophthalmology


Additional Info

The British Journal of Ophthalmology
Two-Year Interim Safety Results of the 0.2 µg/Day Fluocinolone Acetonide Intravitreal Implant for the Treatment of Diabetic Macular Oedema: The Observational PALADIN Study
Br J Ophthalmol 2020 May 27;[EPub Ahead of Print], SE Mansour, DF Kiernan, DB Roth, D Eichenbaum, NM Holekamp, S Kaba, E Werts

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading